Delivery Order SPE2DB25D3012-SPE2DB25FWYMC
Award Date 7/8/25
Potential Completion Date 7/9/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,842.64 firm-fixed-price delivery order is for the supply of Everolimus 0.5 mg tablets. The contract has an ultimate completion date of November 24, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,525.17 firm fixed-price delivery order is for the supply of 0.75 mg Everolimus tablets. The contract has a completion date of June 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,141.89 Firm Fixed Price Delivery Order covers the supply of Everolimus 1 mg tablets for a period ending on February 7, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,488.37 firm fixed-price delivery order is for the supply of Everolimus 0.5 mg tablets, with a period of performance through March 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,184.60 firm fixed-price delivery order covers the supply of EVEROLIMUS 5 MG TABLET UD 28S, with an ultimate completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA). The contract, valued at $30,156.54, is for the delivery of Everolimus 5 mg tablets over the period ending on November 4, 2024. This is a firm fixed-price delivery order contract, which is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an agency of the U.S. Department of Defense. The award is for the delivery of 4,568,520,445 tablets of the medication Everolimus 0.5 mg with a ceiling value of $12,048.19. The contract is a delivery order, with a firm fixed price pricing type. It is not designated as a set-aside contract. The place of performance is...
- This federal contract award, valued at $4,462.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the procurement of 4566759648 - Everolimus 5 mg Tablet UD 28s, a specialty pharmaceutical product. The contract has an ultimate completion date of December 19, 2024 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery...
- This federal contract award is for the delivery of Everolimus 1 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $13,406.09 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, with a focus on supporting the...
- This is a $17,500.49 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4560437634 - EVEROLIMUS 10 MG TABLET 30S. The contract has an ultimate completion date of March 31, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...